XML 68 R53.htm IDEA: XBRL DOCUMENT v3.3.1.900
SEGMENT AND GEOGRAPHIC INFORMATION (Tables)
12 Months Ended
Sep. 30, 2015
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information, by Segment [Table Text Block]
Net revenues, income (loss) from operations and total assets of the Company’s reportable segments are as follows:
 
 
 
Year ended September 30,
 
 
 
2013
 
2014
 
2015
 
 
 
RMB
 
RMB
 
RMB
 
Segment net revenues
 
 
 
 
 
 
 
 
 
 
Seed Production & Distribution
 
 
481,694
 
 
414,891
 
 
376,250
 
Biotech & Product Development
 
 
10,079
 
 
3,250
 
 
3,257
 
Segment total net revenues
 
 
491,773
 
 
418,141
 
 
379,507
 
Inter-segment sales eliminations
 
 
(10,079)
 
 
(3,250)
 
 
(3,257)
 
Reconciliation to consolidated revenues
 
 
481,694
 
 
414,891
 
 
376,250
 
 
 
 
 
 
 
 
 
 
 
 
Segment operating income(loss)
 
 
 
 
 
 
 
 
 
 
Seed Production & Distribution
 
 
51,831
 
 
10,691
 
 
38,709
 
Biotech & Product Development
 
 
(21,141)
 
 
(24,328)
 
 
(26,501)
 
Total segment operating income(loss)
 
 
30,690
 
 
(13,637)
 
 
12,208
 
 
 
 
 
 
 
 
 
 
 
 
Less: Unallocated corporate operating expenses, net
 
 
12,527
 
 
10,842
 
 
10,868
 
Reconciliation to consolidated income (loss) from operations
 
 
18,163
 
 
(24,479)
 
 
1,340
 
 
 
 
September 30,
 
 
 
2014
 
2015
 
 
 
RMB
 
RMB
 
Segment identifiable assets:
 
 
 
 
 
 
 
Seed Production &Distribution
 
 
981,896
 
 
916,088
 
Biotech & Product Development
 
 
204,420
 
 
187,223
 
Segment totalidentifiable assets
 
 
1,186,316
 
 
1,103,311
 
Receivables elimination
 
 
(121,446)
 
 
(117,482)
 
Reconciliation to consolidated total assets
 
 
1,064,870
 
 
985,829
 
  
Supplemental disclosures of segment information:
 
 
 
Year ended September 30,
 
 
 
2013
 
2014
 
2015
 
 
 
RMB
 
RMB
 
RMB
 
Segment depreciation and amortization
 
 
 
 
 
 
 
 
 
 
Seed Production & Distribution
 
 
27,206
 
 
27,567
 
 
29,668
 
Biotech &Product Development
 
 
958
 
 
957
 
 
879
 
Reconciliation to consolidated depreciation and amortization
 
 
28,164
 
 
28,524
 
 
30,547
 
 
 
 
 
 
 
 
 
 
 
 
Segment capital expenditure to long-lived assets
 
 
 
 
 
 
 
 
 
 
Seed Production & Distribution
 
 
66,348
 
 
22,615
 
 
20,531
 
Biotech & Product Development
 
 
1,255
 
 
-
 
 
-
 
Reconciliation to consolidated expenditure on the purchase of plant and equipment, land use rights and intangible assets
 
 
67,603
 
 
22,615
 
 
20,531